Logo-ijhpm
Int J Health Policy Manag. 2022;11(2): 100-102. doi: 10.34172/ijhpm.2021.49
PMID: 33949818        PMCID: PMC9278601

Editorial

Equitable and Effective Distribution of the COVID-19 Vaccines – A Scientific and Moral Obligation

Agnes Binagwaho 1 * ORCID, Kedest Mathewos 1 ORCID, Sheila Davis 2 ORCID

Cited by CrossRef:

1- Chen Y, Lin Y, Chang Y, Chou W, Yen C. Differences in Sources of Information, Risk Perception, and Cognitive Appraisals between People with Various Latent Classes of Motivation to Get Vaccinated against COVID-19 and Previous Seasonal Influenza Vaccination: Facebook Survey Study with Latent Profile Analysis in Taiwan. Vaccines. 2021;9(10):1203 [Crossref]
2- Li G. Establishing an Equitable Global Access to COVID-19 Vaccines. HBEM. 2022;1:373 [Crossref]
3- Chen Y, Lin Y, Chang Y, Chou W, Yen C. Differences in the Protection Motivation Theory Constructs between People with Various Latent Classes of Motivation for Vaccination and Preventive Behaviors against COVID-19 in Taiwan. IJERPH. 2021;18(13):7042 [Crossref]
4- Bwire G, Ario A, Eyu P, Ocom F, Wamala J, Kusi K, Ndeketa L, Jambo K, Wanyenze R, Talisuna A. The COVID-19 pandemic in the African continent. BMC Med. 2022;20(1) [Crossref]
5- George R, Utunen H, Ndiaye N, Tokar A, Mattar L, Piroux C, Gamhewage G. Ensuring equity in access to online courses: Perspectives from the WHO health emergency learning response. World Med & Health Policy. 2022;14(2):413 [Crossref]
6- Tian Y, Hu D, Li Y, Yang L. Development of therapeutic vaccines for the treatment of diseases. Mol Biomed. 2022;3(1) [Crossref]
7- Eslava-Schmalbach J, Rosero E, Garzón-Orjuela N. Global control of COVID-19: good vaccines may not suffice. 2021;45:1 [Crossref]
8- Ogbuokiri B, Ahmadi A, Nia Z, Mellado B, Wu J, Orbinski J, Asgary A, Kong J. Vaccine Hesitancy Hotspots in Africa: An Insight From Geotagged Twitter Posts. IEEE Trans Comput Soc Syst. 2024;11(1):1325 [Crossref]
9- Shao Q. Why does the COVAX facility fail to bridge the ‘immunization gap’?. J Public Health Pol. 2024;45(1):126 [Crossref]
10- Zabinsky Z, Zameer M, Petroianu L, Muteia M, Coelho A. Route Optimization Tool (RoOT) for distribution of vaccines and health products. Gates Open Res. 2021;5:34 [Crossref]
11- Moradzadeh M, Karamouzian M, Najafizadeh S, Yazdi-Feyzabadi V, Haghdoost A. International Journal of Health Policy and Management (IJHPM): A Decade of Advancing Knowledge and Influencing Global Health Policy (2013-2023). Int J Health Policy Manag. 2023;12:8124 [Crossref]
12- Borowicz J, Zhang Z, Day G, Pinto da Costa M. Vaccine equity in COVID-19: a meta-narrative review. BMJ Glob Health. 2022;7(12):e009876 [Crossref]
13- Geetha D, Kronbichler A, Rutter M, Bajpai D, Menez S, Weissenbacher A, Anand S, Lin E, Carlson N, Sozio S, Fowler K, Bignall R, Ducharlet K, Tannor E, Wijewickrama E, Hafidz M, Tesar V, Hoover R, Crews D, Varnell C, Danziger-Isakov L, Jha V, Mohan S, Parikh C, Luyckx V. Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions. Nat Rev Nephrol. 2022;18(11):724 [Crossref]
14- Lucero-Prisno D, Ogunkola I, Esu E, Adebisi Y, Lin X, Li H. Can Africa achieve herd immunity?. glob health res policy. 2021;6(1) [Crossref]
15- Sayin H, Gaillard C, Henry A, Cabelguenne D, Armoiry X. Impact du nouveau règlement européen 2017/745 relatif aux dispositifs médicaux sur l’activité des pharmacies hospitalières : exemple de la fonction d’approvisionnement pharmaceutique au sein d’un centre hospitalo-universitaire français. Annales Pharmaceutiques Françaises. 2022;80(5):730 [Crossref]